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novel natural products bygenomemin-
ingwithout requiring geneticmanipula-
tion of the producing organism, linkage
between the metabolite isolated and
the orphan gene cluster hypothesized
to direct its production still needs
to be established. This is usually
achieved by demonstrating that in-
activation of a biosynthetic gene abro-
gates production of the metabolite or
that transfer of the gene cluster to
a heterologous host results in metabo-
lite production (Figure 1). Thus, genetic
manipulations are ultimately still
required.
It will be interesting to see whether
the genomisotopic approach can be
applied to the identification of other
novel compounds whose existence is
implicated by analysis of genome se-
quence data. Continued development
of predictive bioinformatics tools for
natural product biosyntheticmachinery
is essential to ensure broad applicabil-
ity of the genomisotopic approach.
Nevertheless, the recent emergence
of diversemethodologies for newnatu-
ral product discovery by genome min-
ing may provide the impetus needed
to nudge pharmaceutical companies
back into large-scale natural product
drug discovery programs.
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Using an in vivo selection strategy, Kehayova and Liu identified anRNAmolecule capable of silencing
gene transcription in yeast [1]. In doing so, they expand the repertoire of RNA molecules performing
long-believed ‘‘protein-only’’ cellular functions.The discovery of catalytic RNA more
than 20 years ago initiated a new era
of RNA research [2, 3]. This first dis-
covery that RNA can be both an infor-
mational molecule and a catalyst
caused a shift in thinking about RNA
in general. In a virtually continual ex-
pansion, a plethora of RNA molecules
with diverse catalytic and regulatory
functions have emerged, indicatingthat RNA molecules can perform cru-
cial roles within the cell once believed
to be unique to the realm of proteins.
The molecular basis for this diversity
originates from the conformational
flexibility and functional versatility of
this macromolecule. In many ways, RNA
seems to be more akin to proteins
than to the chemically related DNA.
Like proteins, RNA can adopt complexChemistry & Biology 14, January 2007three-dimensional structures for the
precise presentation of chemicalmoie-
ties that are essential for its function
as a biological catalyst, structural scaf-
fold, or regulator of gene expression.
Molecular engineers began to har-
ness Darwinian evolution in combina-
tion with rational design to optimize
the known functions of RNA, but also
to create ‘‘new’’ ones. For example,ª2007 Elsevier Ltd All rights reserved 9
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PreviewsFigure 1. Selection Scheme for an RNA-Based Transcriptional Silencer
(A) Transcriptional silencing at the HMR-E locus. Binding of regulatory proteins ORC, Rap1, and
Abf1 leads to recruitment of the Sir proteins and establishes a heterochromatic state that results
in gene silencing.
(B) An MS2 hairpin-linked N40-RNA library transcribed from a PolIII promoter localizes to the
promoter of an URA3 reporter gene through the respective DNA and RNA binding activities of
a MS2 coat protein-Gal4 DNA binding domain fusion protein (Gal4::MS2). RNAs capable of silenc-
ing the expression of the URA3 reporter gene enable survival on media containing 5-FOA.RNA-based molecular switches and
sensors were engineered [4, 5] and
developed for conditional control of
gene expression [6]. The subsequent
discovery of natural riboswitches re-
vealed that this principal was actually
perfected millions of years ago by
nature [7]. The engineered RNA-based
regulators make use of a variety of
mechanisms to exert their control. In
bacteria, they target mainly translation
initiation by inhibiting access to the ri-
bosomal binding site [8, 9]. Eukaryotic
switches target ribosomal access by
preventing cap binding [10], but can
also interfere with steps of gene ex-
pression further downstream like scan-
ning, splicing, and mRNA degradation
(reviewed in [11]). Moving away from
negative regulation, Liu and colleagues
evolved an RNA-based transcriptional
activator capableof activatinggeneex-
pression in yeast, probably by recruit-
ing components of the transcriptional
machinery [12].
In this issue of Chemistry & Biology,
Kehayova and Liu expand the scope
of designer RNAs by selection of an
RNAi-independent transcriptional si-
lencer [1]. Their evolution strategy
was based on transcriptional silencing
at the HMR-E locus (Figure 1A). The10 Chemistry & Biology 14, January 2007HMR-E silencer consists of binding
sites for three essential factors: the
origin recognition complex (ORC) and
the two transcription activators Rap1
and Abf1. These factors recruit, via
protein-protein interactions, the silent
information regulator proteins Sir1-4,
leading to heterochromatin formation
and subsequent silencing of down-
stream genes [13]. Using a yeast
three-hybrid system, the authors
evolved an RNA molecule to replace
the recruiting proteins (Figure 1B). In
the selection strain used, the E and B
sites of the HMR-E locus were re-
placed with a Gal4 binding site. This
alteration results in the loss of gene
silencing and the expression of a
URA3 reporter gene. An RNA-library,
consisting of an N40 variable region
sandwiched between MS2 RNA hair-
pins and a RNA polymerase III RNase
P RNA (RPR) terminator, was then lo-
calized to the URA3 promoter region
through the DNA- and RNA-binding
activities of an MS2 coat protein-Gal4
DNA binding domain fusion protein.
To identify active RNAs, they per-
formed classical FOA selection: RNAs
capable of silencing the expression of
the URA3 gene enable survival on
media containing 5-fluoroorotic acidª2007 Elsevier Ltd All rights reserved(5-FOA), which otherwise would lead
to rapid cell death by URA3-mediated
conversion of the compound into the
toxic 50 fluorouridine monophosphate.
After two rounds of selection, clones
capable of growing in the presence of
5-FOA were identified. One of the
clones isolated showed activity com-
parable toknown transcriptional repres-
sors directly recruited to the HMR-E
locus by fusion to the Gal4 binding do-
main [14]. Random mutations were
introduced into this silencing-active
clone, and the resulting RNA library
subjected to an additional round of se-
lection; this led to the isolation of an
even more potent silencer than the pa-
rental RNA. Furthermore, a detailed
mutagenesis study was performed to
elucidate the structural properties of
the most active RNA-transcriptional
repressor. Finally, using genetic stud-
ies, the authors provided evidence
that the evolved RNA establishes
gene silencing via the traditional Sir
protein-dependent mechanism. Dele-
tion of any of the four Sir proteins
required for HMR-E repression abol-
ished silencing through the RNA com-
pletely. Furthermore, they demon-
strated that deletion of all three
silencer (HMR-E A, E and B) elements
allows only a low level of repression.
This result is consistent with previous
findings that full silencing of the HMR-
E locus depends on a least two active
silencer elements [15].
There are at least three remarkable
aspects of this report: (1) the identifica-
tion of a potent silencer from a modest
library size, (2) the ability of RNA to
silence a gene independent of the
RNAi pathway, and (3) the ability to
select an RNA molecule with a desired
in vivo function. It is surprising that
it was possible to identify a potent
silencer from an RNA library of only
5 3 104 members. This may be ex-
plained by the fact that the target was
not a single component like a regula-
tory protein. Instead, an entire bio-
logical process was targeted which
increases thenumber ofpotential inter-
action partners. Thereby, the success
rate of directed evolution is advanced
and allows a dramatic reduction in the
required complexity of the initial selec-
tion pool. This approach clearly shows
the tremendous potential of in vivo
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highlight that the evolvedRNA silences
gene expression independent of the
RNAi pathway. This observation sug-
gests that, although there are no
known RNA-based transcriptional si-
lencers, and S. cerevisiae seems to
lack proteins related to the RNAi path-
way [16], natural RNA-based gene
silencing may also exist in budding
yeast. By using functional versatility
combined with the powerful ways in
which RNA can be manipulated and
characterized, Kehayova and Liu
nicely demonstrate that an in vivo ac-
tive RNAmolecule with a desired intra-
cellular function can be developed.
Thereby, they extend the scope of
in vivo functional RNAs that can be
used as regulatory elements. Further-
more, their straightforward design
and use of a simple selection systempromises to add more custom-crafted
RNA molecules as novel tools to the
experimental repertoire of molecular
biology.
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